Cite
HARVARD Citation
Kim, B. et al. (2022). Expert consensus on the management of adverse events in patients receiving lenvatinib for hepatocellular carcinoma. Journal of gastroenterology and hepatology. 37 (3), pp. 428-439. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Kim, B. et al. (2022). Expert consensus on the management of adverse events in patients receiving lenvatinib for hepatocellular carcinoma. Journal of gastroenterology and hepatology. 37 (3), pp. 428-439. [Online].